What does Larimar Therapeutics, Inc. do?

Jun 22 2025 07:20 PM IST
share
Share Via
Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases using cell penetrating peptide technology. It has a market cap of $172.24 million and reported a net profit loss of $29 million as of March 2025.
Overview:
Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for complex rare diseases using its cell penetrating peptide technology platform, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap. Financial Snapshot: Most recent Net Profit: -29 Million (Quarterly Results - Mar 2025) Market cap: USD 172.24 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.08 Return on Equity: -66.01% Price to Book: 1.19 Contact Details: Address: THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD PA: 19004 Tel: 1 617 6224003 Fax: 1 302 6555049 Website: https://larimartx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Larimar Therapeutics, Inc.?
Jun 22 2025 06:30 PM IST
share
Share Via